American International Group, Inc. Exagen Inc. Transaction History

American International Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.18 - $7.74 $21,422 - $39,667	-5,125 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$7.12 - $11.06 $2,570 - $3,992	-361 Reduced 6.58%	5,125 $41,000
Q4 2021 Feb 11, 2022	SELL	$8.97 - $14.08 $1,462 - $2,295	-163 Reduced 2.89%	5,486 $64,000
Q3 2021 Nov 12, 2021	SELL	$10.25 - $15.21 $4,325 - $6,418	-422 Reduced 6.95%	5,649 $77,000
Q2 2021 Aug 13, 2021	BUY	$12.4 - $17.92 $40,771 - $58,920	3,288 Added 118.15%	6,071 $91,000
Q1 2021 May 07, 2021	BUY	$13.9 - $22.0 $97 - $154	7 Added 0.25%	2,783 $49,000
Q4 2020 Feb 12, 2021	SELL	$11.19 - $16.05 $884 - $1,267	-79 Reduced 2.77%	2,776 $37,000
Q3 2020 Nov 04, 2020	SELL	$10.56 - $16.69 $686 - $1,084	-65 Reduced 2.23%	2,855 $31,000
Q2 2020 Aug 12, 2020	BUY	$11.0 - $16.7 $10,549 - $16,015	959 Added 48.9%	2,920 $36,000
Q1 2020 May 04, 2020	SELL	$12.7 - $25.95 $1,435 - $2,932	-113 Reduced 5.45%	1,961 $31,000
Q4 2019 Feb 05, 2020	BUY	$12.61 - $28.48 $26,153 - $59,067	2,074 New	2,074 $53,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $81.6M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.